1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook( 2012-2022) 1.4.4.2 Egypt Market States and Outlook( 2012-2022) 1.4.4.3 Saudi Arabia Market States and Outlook( 2012-2022) 1.4.4.4 South Africa Market States and Outlook( 2012-2022) 1.4.4.5 Nigeria Market States and Outlook( 2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Sanofi 2.1.1 Business Overview 2.1.2 Gaucher Disease Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Sanofi Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share( 2016-2017) 2.2 Shire 2.2.1 Business Overview 2.2.2 Gaucher Disease Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Shire Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share( 2016-2017) 2.3 Actelion Pharma 2.3.1 Business Overview 2.3.2 Gaucher Disease Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Actelion Pharma Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share( 2016-2017) 2.4 Pfizer 2.4.1 Business Overview 2.4.2 Gaucher Disease Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Pfizer Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share( 2016-2017) 2.5 ISU Pharm 2.5.1 Business Overview 2.5.2 Gaucher Disease Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 ISU Pharm Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share( 2016-2017) 3 Global Gaucher Disease Market Competition, by Manufacturer 3.1 Global Gaucher Disease Sales and Market Share by Manufacturer 3.2 Global Gaucher Disease Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Gaucher Disease Manufacturer Market Share 3.3.2 Top 6 Gaucher Disease Manufacturer Market Share 3.4 Market Competition Trend